Mondrian Investment Partners LTD held its position in Balchem Corporation (NASDAQ:BCPC) during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 26,804 shares of the basic materials company’s stock at the end of the second quarter. Mondrian Investment Partners LTD owned about 0.08% of Balchem Corporation worth $2,083,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of BCPC. Sei Investments Co. increased its position in Balchem Corporation by 117.9% in the second quarter. Sei Investments Co. now owns 2,465 shares of the basic materials company’s stock valued at $191,000 after buying an additional 1,334 shares during the last quarter. American Capital Management Inc. acquired a new position in Balchem Corporation during the second quarter valued at $218,000. Tokio Marine Asset Management Co. Ltd. acquired a new position in Balchem Corporation during the second quarter valued at $233,000. Municipal Employees Retirement System of Michigan increased its position in Balchem Corporation by 4.0% in the second quarter. Municipal Employees Retirement System of Michigan now owns 7,500 shares of the basic materials company’s stock valued at $583,000 after buying an additional 290 shares during the last quarter. Finally, Cardinal Capital Management increased its position in Balchem Corporation by 12.9% in the second quarter. Cardinal Capital Management now owns 16,965 shares of the basic materials company’s stock valued at $1,318,000 after buying an additional 1,944 shares during the last quarter. Hedge funds and other institutional investors own 85.34% of the company’s stock.
Balchem Corporation (NASDAQ:BCPC) opened at 74.48 on Friday. Balchem Corporation has a 1-year low of $65.37 and a 1-year high of $89.50. The stock has a market cap of $2.38 billion, a P/E ratio of 38.59 and a beta of 1.10. The stock has a 50 day moving average of $77.35 and a 200 day moving average of $80.84.
Balchem Corporation (NASDAQ:BCPC) last released its quarterly earnings results on Friday, August 4th. The basic materials company reported $0.64 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.01. Balchem Corporation had a net margin of 10.99% and a return on equity of 14.99%. The firm had revenue of $147.08 million during the quarter. Equities analysts anticipate that Balchem Corporation will post $2.48 EPS for the current fiscal year.
Separately, BidaskClub downgraded shares of Balchem Corporation from a “sell” rating to a “strong sell” rating in a research note on Monday, July 31st.
In other news, Director Edward Mcmillan sold 2,557 shares of the company’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $81.09, for a total transaction of $207,347.13. Following the completion of the sale, the director now owns 25,739 shares of the company’s stock, valued at approximately $2,087,175.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.59% of the stock is owned by corporate insiders.
Balchem Corporation Company Profile
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corporation and related companies with MarketBeat.com's FREE daily email newsletter.